INSURANCE: Creates the PACE Task Force to prioritize access, care, and education on GLP-1 medications
Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
Summary
The resolution establishes a PACE Task Force to examine the history, availability, and insurance costs of GLP‑1 medications used for diabetes and weight loss. It will include representatives from the insurance commissioner, health‑plan association, health department, board of pharmacy, and an endocrinology provider, and must report its findings to the legislature by February 12, 2027. The study aims to inform future policy on pricing, coverage, and equity.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HCR 120 changes status, plus AI-powered summaries and stage predictions.
Sign up free